BAX

Baxter International Inc. (BAX) Stock Price

Closed
BAX
$25.30
-$0.05(-0.19%)

Content updated: 2026-11-22 23:02:04

Yesterday's Close
$25.35
Today's Open
$25.32
Today's High
$26.04
Today's Low
$25.22
Volume
10.16M shares
52-Week Range
$17.76-$30.00

As of 2026-11-22 23:02:04, Baxter International Inc. (BAX) was quoted at $25.30, a change of -$0.05 (-0.19%) from the previous close. The day's range was $25.22–$26.04, and the 52-week range was $17.76–$30.00.

Why Is Baxter International Inc. (BAX) Stock Falling?

AI Stock Price Analysis

Content updated: 2026-11-20 23:31:20

BAX spiked to 26.07 USD at the open and then faded to around 25.39 USD by the cutoff, up 0.04% from the prior close but on only 0.31x normal volume and still below volume-weighted average price (VWAP); the late-October guidance raise and deleveraging progress remain the main backdrop.

Past 1W-1.55%Period Low $24.85Period High $26.45
Past 1M+2.66%Period Low $22.50Period High $27.08
Past 3M-3.71%Period Low $22.50Period High $27.08
Past 1Y+44.42%Period Low $15.73Period High $30.00

About Baxter International Inc. (BAX)

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
Ticker / Exchanges
BAX / NYSE
Industry / Sector
Medical - Instruments & Supplies / Healthcare
CEO
Andrew Hider
Headquarters
Deerfield,IL,US
Official Website
https://www.baxter.com
Listing Date
1981-10-27

Recent Company Events

  • 2027-02-11
    Earnings Report · ExpectedOn 2027-02-11, the 2026/Q4 earnings report is expected to be released.

Baxter International Inc. (BAX) Derivatives Trading

Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Baxter International Inc. (BAX) Company Financials

Valuation and Shares

Market Cap
$13.13B
P/E Ratio (TTM)
-17.88
P/B Ratio
2.02
Shares Outstanding
517.34M shares
Float Shares
514.65M shares
Dividend Yield (TTM)
0.16%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-10-29

Operating Revenue (Actual)

$2.97B

Same Period Last Year: +4.97%

Earnings per Share (Actual)

$0.58

Same Period Last Year: -15.94%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$10.05B$10.36B$10.63B$11.24B
Net Profit-$2.43B$2.65B-$649.00M-$957.00M
Operating Cash Flow$1.21B$1.72B$1.01B$845.00M

BAX FAQ

What is the current stock price of Baxter International Inc. (BAX)?

x
As of 2026-11-22 23:02 (UTC+8), the latest available quote for Baxter International Inc. (BAX) is $25.30 USD, with a change of -$0.05 USD (-0.19%) from the previous trading day's close. Current market status: Closed.

Which exchange is BAX listed on?

x

How has Baxter International Inc. stock performed over the past month?

x

What is the market cap of Baxter International Inc.?

x

What are Baxter International Inc.'s latest financial results?

x

What factors may affect the stock price of Baxter International Inc. (BAX)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.